Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis

被引:547
作者
Jacobsen, S. M. [2 ]
Stickler, D. J. [3 ]
Mobley, H. L. T. [4 ]
Shirtliff, M. E. [1 ,2 ]
机构
[1] Univ Maryland, Sch Dent, Dept Biomed Sci, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA
[3] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3TL, Wales
[4] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA
关键词
D O I
10.1128/CMR.00019-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Catheter-associated urinary tract infections (CAUTIs) represent the most common type of nosocomial infection and are a major health concern due to the complications and frequent recurrence. These infections are often caused by Escherichia coli and Proteus mirabilis. Gram-negative bacterial species that cause CAUTIs express a number of virulence factors associated with adhesion, motility, biofilm formation, immunoavoidance, and nutrient acquisition as well as factors that cause damage to the host. These infections can be reduced by limiting catheter usage and ensuring that health care professionals correctly use closed-system Foley catheters. A number of novel approaches such as condom and suprapubic catheters, intermittent catheterization, new surfaces, catheters with antimicrobial agents, and probiotics have thus far met with limited success. While the diagnosis of symptomatic versus asymptomatic CA UTIs may be a contentious issue, it is generally agreed that once a catheterized patient is believed to have a symptomatic urinary tract infection, the catheter is removed if possible due to the high rate of relapse. Research focusing on the pathogenesis of CAUTIs will lead to a better understanding of the disease process and will subsequently lead to the development of new diagnosis, prevention, and treatment options.
引用
收藏
页码:26 / +
页数:36
相关论文
共 476 条
[51]   An electrified catheter to resist encrustation by Proteus mirabilis biofilm [J].
Chakravarti, A ;
Gangodawila, S ;
Long, MJ ;
Morris, NS ;
Blacklock, ARE ;
Stickler, DJ .
JOURNAL OF UROLOGY, 2005, 174 (03) :1129-1132
[52]   INTERNALIZATION OF PROTEUS-MIRABILIS BY HUMAN RENAL EPITHELIAL-CELLS [J].
CHIPPENDALE, GR ;
WARREN, JW ;
TRIFILLIS, AL ;
MOBLEY, HLT .
INFECTION AND IMMUNITY, 1994, 62 (08) :3115-3121
[53]   NOSOCOMIAL OUTBREAK OF INFECTIONS DUE TO MULTIPLY RESISTANT PROTEUS-MIRABILIS - ROLE OF INTESTINAL COLONIZATION AS A MAJOR RESERVOIR [J].
CHOW, AW ;
TAYLOR, PR ;
YOSHIKAWA, TT ;
GUZE, LB .
JOURNAL OF INFECTIOUS DISEASES, 1979, 139 (06) :621-627
[54]   37-kDa laminin receptor precursor modulates cytotoxic necrotizing factor 1-mediated RhoA activation and bacterial uptake [J].
Chung, JW ;
Hong, SJ ;
Kim, KJ ;
Goti, D ;
Stins, MF ;
Shin, S ;
Dawson, VL ;
Dawson, TM ;
Kim, KS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (19) :16857-16862
[55]   THE INFLUENCE OF BACTERIA ON STRUVITE CRYSTAL HABIT AND ITS IMPORTANCE IN URINARY STONE FORMATION [J].
CLAPHAM, L ;
MCLEAN, RJC ;
NICKEL, JC ;
DOWNEY, J ;
COSTERTON, JW .
JOURNAL OF CRYSTAL GROWTH, 1990, 104 (02) :475-484
[56]   ENTEROBACTERIAL FIMBRIAE [J].
CLEGG, S ;
GERLACH, GF .
JOURNAL OF BACTERIOLOGY, 1987, 169 (03) :934-938
[57]   H-NS is a repressor of the Proteus mirabilis urease transcriptional activator gene ureR [J].
Coker, C ;
Bakare, OO ;
Mobley, HLT .
JOURNAL OF BACTERIOLOGY, 2000, 182 (09) :2649-2653
[58]   Pathogenesis of Proteus mirabilis urinary tract infection [J].
Coker, C ;
Poore, CA ;
Li, X ;
Mobley, HLT .
MICROBES AND INFECTION, 2000, 2 (12) :1497-1505
[59]   Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract [J].
Connell, H ;
Agace, W ;
Klemm, P ;
Schembri, M ;
Marild, S ;
Svanborg, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (18) :9827-9832
[60]   MOLECULAR-CLONING OF PROTEUS-MIRABILIS UROEPITHELIAL CELL ADHERENCE (UCA) GENES [J].
COOK, SW ;
MODY, N ;
VALLE, J ;
HULL, R .
INFECTION AND IMMUNITY, 1995, 63 (05) :2082-2086